✦ LIBER ✦

Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection

✍ Scribed by Marelli, C.

Book ID: 113013248
Publisher: Springer
Year: 1999
Tongue: English
Weight: 494 KB
Volume: 9
Category: Article
ISSN: 0938-7994
DOI: 10.1007/pl00014070

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temporal and spatial heterogenelty of my

Temporal and spatial heterogenelty of myocardial contrast enhancement, despite lack of posterior wall attenuation, with a new contrast agent, NC100100

✍ N. Masani; P. Nikutta; M. Arsonaull; C. Kimmolstiol; N. Pandian 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Clinical experience with AF0150 (Imagent

Clinical experience with AF0150 (Imagent US), a new ultrasound contrast agent

✍ Pelura, Timothy J. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Safety and preliminary findings with the

Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography

✍ Andrew M. Taylor; Jonathan R. Panting; Jennifer Keegan; Peter D. Gatehouse; Dipt 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 1 views

A new contrast agent for ultrasound imag

A new contrast agent for ultrasound imaging (Sonovue) to improve the detection of renal cell tumour's pseudocapsule: Preliminary experience

✍ C. Magno; G. Assenti; A. Gali; M. Caramia; G. Anastasi; A. Inferrena; D. Melloni 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Preliminary European intravenous clinica

Preliminary European intravenous clinical experience with a new, low osmolar, nonionic contrast medium: ioversol (OptirayR)

✍ Le Mignon, M.M; Azau, C; Arthaud, A; Bonnemain, B 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 748 KB

Preliminary clinical trial of gadodiamid

Preliminary clinical trial of gadodiamide injection: A new nonionic gadolinium contrast agent for MR imaging

✍ Gabriela D. Kaplan; Alex M. Aisen; S. Rao Aravapalli 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

The safety and efficacy of a newly developed intravenous formulation of the nonionic contrast agent gadolinium diethylenetriaminepentaacetic acid-bis(methylamide), formulated as gadodiamide injection, was investigated. In 30 patients who underwent spin-echo magnetic resonance (MR) imaging before and